Crexendo (CXDO)
(Real Time Quote from BATS)
$3.71 USD
-0.09 (-2.37%)
Updated May 21, 2024 03:21 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for Crexendo Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 53 | 38 | 28 | 16 | 14 |
Cost Of Goods | 22 | 14 | 11 | 5 | 4 |
Gross Profit | 32 | 24 | 17 | 11 | 10 |
Selling & Adminstrative & Depr. & Amort Expenses | 33 | 61 | 20 | 10 | 9 |
Income After Depreciation & Amortization | -2 | -37 | -3 | 1 | 1 |
Non-Operating Income | 2 | 1 | 0 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 0 | -36 | -3 | 2 | 1 |
Income Taxes | 0 | -1 | 0 | -6 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | -35 | -2 | 8 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 0 | -35 | -2 | 8 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2 | -2 | -1 | 1 | 1 |
Depreciation & Amortization (Cash Flow) | 4 | 35 | 2 | 0 | 0 |
Income After Depreciation & Amortization | -2 | -37 | -3 | 1 | 1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.95 | 22.94 | 20.28 | 17.42 | 15.56 |
Diluted EPS Before Non-Recurring Items | 0.11 | -0.03 | -0.01 | 0.47 | 0.07 |
Diluted Net EPS (GAAP) | -0.01 | -1.54 | -0.12 | 0.46 | 0.07 |
Fiscal Year end for Crexendo Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 14.29 | 14.16 | 13.87 | 12.67 | 12.49 |
Cost Of Goods | 5.23 | 5.80 | 5.42 | 5.27 | 5.07 |
Gross Profit | 9.06 | 8.36 | 8.45 | 7.40 | 7.42 |
SG&A, R&D, and Dept/Amort Expenses | 8.57 | 8.33 | 8.09 | 7.92 | 9.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.49 | 0.03 | 0.36 | -0.52 | -1.58 |
Non-Operating Income | -0.01 | -1.42 | 1.41 | 0.03 | 0.06 |
Interest Expense | 0.01 | 0.00 | 0.04 | 0.03 | 0.04 |
Pretax Income | 0.46 | 0.08 | 1.74 | -0.52 | -1.56 |
Income Taxes | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 0.43 | 0.06 | 1.70 | -0.55 | -1.58 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 0.43 | 0.06 | 1.70 | -0.55 | -1.58 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 30.14 | 26.07 | 27.68 | 25.97 | 25.73 |
Diluted EPS Before Non-Recurring Items | 0.04 | 0.03 | 0.09 | 0.01 | -0.03 |
Diluted Net EPS (GAAP) | 0.01 | 0.01 | 0.06 | -0.02 | -0.06 |